Catalyst Wire Dossier Catalyst Wire Dossier

ophthalmic phentolamine mesylate

phentolamine mesylate · Ocuphire Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ophthalmic phentolamine mesylate, covering 2023-07-12 to 2023-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma [Phase 2]

See pricing